Century Therapeutics Inc (NASDAQ:IPSC)’s traded shares stood at 1.33 million during the last session, with the company’s beta value hitting 1.75. At the close of trading, the stock’s price was $0.42, to imply an increase of 7.56% or $0.03 in intraday trading. The IPSC share’s 52-week high remains $4.43, putting it -954.76% down since that peak but still an impressive 9.52% since price per share fell to its 52-week low of $0.38. The company has a valuation of $36.01M, with an average of 0.56 million shares in intraday trading volume over the past 10 days and average of 484.67K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Century Therapeutics Inc (IPSC), translating to a mean rating of 1.25. Of 4 analyst(s) looking at the stock, 0 analyst(s) give IPSC a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 3 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.79.
Century Therapeutics Inc (NASDAQ:IPSC) trade information
After registering a 7.56% upside in the last session, Century Therapeutics Inc (IPSC) has traded red over the past five days. The 5-day price performance for the stock is -10.90%, and -30.39% over 30 days. With these gigs, the year-to-date price performance is -58.56%. Short interest in Century Therapeutics Inc (NASDAQ:IPSC) saw shorts transact 3.38 million shares and set a 7.24 days time to cover.
The extremes give us $5 and $5 for target low and target high price respectively. As such, IPSC has been trading -1090.48% off suggested target high and -1090.48% from its likely low.
Century Therapeutics Inc (IPSC) estimates and forecasts
The rating firms project that company’s revenue will grow 672.46% compared to the previous financial year.
Revenue forecast for the current quarter as set by 5 analysts is 49.55M. Meanwhile, for the current quarter, a total of 5 analyst(s) estimate revenue growth to 4.51M.Earnings reports from the last fiscal year show that sales brought in 855k and 771k respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 5,695.42% before jumping 485.47% in the following quarter.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 18.46% for the past 5-year period. While 2025 is set for a 27.78% return in earnings, projections for the next 5 years are at 6.80% annually.
IPSC Dividends
Century Therapeutics Inc has its next earnings report out on 2025-Mar-18. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Century Therapeutics Inc (NASDAQ:IPSC)’s Major holders
Century Therapeutics Inc insiders hold 27.48% of total outstanding shares, with institutional holders owning 57.26% of the shares at 78.96% float percentage. In total, 57.26% institutions holds shares in the company, led by BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC. As of 2024-06-30, the company held over 5.41 million shares (or 8.6848% of shares), all amounting to roughly $13.8 million.
The next major institution holding the largest number of shares is VR ADVISER, LLC with 5.39 million shares, or about 8.651% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $13.74 million.
We also have VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF as the top two Mutual Funds with the largest holdings of the Century Therapeutics Inc (IPSC) shares. Going by data provided on Dec 31, 2024 , VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund holds roughly 1.31 shares. This is just over 1.53% of the total shares, with a market valuation of $0.55 million. Data from the same date shows that the other fund manager holds a little less at 1.02, or 1.19% of the shares, all valued at about 0.43 million.
